Progestin modulates the lipid profile and sensitivity of breast cancer cells to docetaxel

[1]  H. Sasano,et al.  Inhibition of estrogen actions in human gynecological malignancies: New aspects of endocrine therapy for endometrial cancer and ovarian cancer , 2011, Molecular and Cellular Endocrinology.

[2]  M. Bellanda,et al.  "Metabolic reprogramming" in ovarian cancer cells resistant to cisplatin. , 2011, Current cancer drug targets.

[3]  B. Casetta,et al.  High-throughput plasma docetaxel quantification by liquid chromatography-tandem mass spectrometry. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[4]  J. Manson,et al.  Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. , 2010, JAMA.

[5]  L. Zeng,et al.  Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase. , 2010, Endocrine-related cancer.

[6]  Daniel Morvan,et al.  Pharmacometabolomics of docetaxel-treated human MCF7 breast cancer cells provides evidence of varying cellular responses at high and low doses , 2010, Breast Cancer Research and Treatment.

[7]  D. Nomura,et al.  Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis , 2010, Cell.

[8]  M. Bonini,et al.  Inhibition of StearoylCoA Desaturase-1 Inactivates Acetyl-CoA Carboxylase and Impairs Proliferation in Cancer Cells: Role of AMPK , 2009, PloS one.

[9]  C. Watson,et al.  Preface , 2009, Journal of Mammary Gland Biology and Neoplasia.

[10]  V. Borges,et al.  Pregnancy and Breast Cancer: when They Collide , 2009, Journal of Mammary Gland Biology and Neoplasia.

[11]  T. Tsuruo,et al.  De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy , 2009, British Journal of Cancer.

[12]  J. Graham,et al.  Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression , 2009, Nuclear receptor signaling.

[13]  C. Lange.  Challenges to defining a role for progesterone in breast cancer , 2008, Steroids.

[14]  K. Horwitz,et al.  Progestins in hormone replacement therapies reactivate cancer stem cells in women with preexisting breast cancers: a hypothesis. , 2008, The Journal of clinical endocrinology and metabolism.

[15]  K. Horwitz,et al.  Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts , 2008, Proceedings of the National Academy of Sciences.

[16]  Yang Liu,et al.  A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction , 2008, Molecular Cancer Therapeutics.

[17]  J. Menéndez,et al.  Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis , 2007, Nature Reviews Cancer.

[18]  M. Prentki,et al.  Upregulation of cellular triacylglycerol - free fatty acid cycling by oleate is associated with long-term serum-free survival of human breast cancer cells. , 2007, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[19]  D. Hasenclever,et al.  Role of the progesterone receptor for paclitaxel resistance in primary breast cancer , 2007, British Journal of Cancer.

[20]  Wen-Lin Kuo,et al.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.

[21]  F. Kuhajda,et al.  Fatty acid synthase and cancer: new application of an old pathway. , 2006, Cancer research.

[22]  M. Moore,et al.  Progestin inhibition of cell death in human breast cancer cell lines , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[23]  J. Yager,et al.  Estrogen carcinogenesis in breast cancer. , 2006, The New England journal of medicine.

[24]  K. Horwitz,et al.  The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells , 2005, Breast Cancer Research.

[25]  K. Horwitz,et al.  Progestins initiate a luminal to myoepithelial switch in estrogen-dependent human breast tumors without altering growth. , 2005, Cancer research.

[26]  J. Menéndez,et al.  Pharmacological and small interference RNA‐mediated inhibition of breast cancer‐associated fatty acid synthase (oncogenic antigen‐519) synergistically enhances Taxol (paclitaxel)‐induced cytotoxicity , 2005, International journal of cancer.

[27]  M. Prentki,et al.  Oleate Promotes the Proliferation of Breast Cancer Cells via the G Protein-coupled Receptor GPR40* , 2005, Journal of Biological Chemistry.

[28]  J. Vera,et al.  Estrogen and progesterone up-regulate glucose transporter expression in ZR-75-1 human breast cancer cells. , 2003, Endocrinology.

[29]  Richard L Schilsky,et al.  Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  O. Baud,et al.  Effect of medroxyprogesterone acetate on the efficiency of an oral protein-rich nutritional support in HIV-infected patients. , 2003, Reproduction, nutrition, development.

[31]  N. Davidson,et al.  The biology of breast carcinoma , 2003, Cancer.

[32]  J. Auwerx,et al.  Progesterone receptor knockout mice have an improved glucose homeostasis secondary to β-cell proliferation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Heidi D Nelson,et al.  Postmenopausal hormone replacement therapy: scientific review. , 2002, JAMA.

[34]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[35]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[36]  K. Ory,et al.  Apoptosis inhibition mediated by medroxyprogesterone acetate treatment of breast cancer cell lines , 2001, Breast Cancer Research and Treatment.

[37]  M. Prentki,et al.  Oleate activates phosphatidylinositol 3-kinase and promotes proliferation and reduces apoptosis of MDA-MB-231 breast cancer cells, whereas palmitate has opposite effects. , 2000, Cancer research.

[38]  J. Conover,et al.  Progestin effects on long-term growth, death, and Bcl-xL in breast cancer cells. , 2000, Biochemical and biophysical research communications.

[39]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[40]  T. Sugino,et al.  Fatty Acid Synthase Is Expressed Mainly in Adult Hormone-sensitive Cells or Cells with High Lipid Metabolism and in Proliferating Fetal Cells1 , 2000 .

[41]  E Riboli,et al.  Fatty‐acid composition in serum phospholipids and risk of breast cancer: An incident case‐control study in Sweden , 1999, International journal of cancer.

[42]  V. Lin,et al.  Progestins inhibit the growth of MDA-MB-231 cells transfected with progesterone receptor complementary DNA. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[43]  K. Horwitz,et al.  Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). , 1997, Molecular endocrinology.

[44]  K. Howell,et al.  Characterization of the Golgi complex cleared of proteins in transit and examination of calcium uptake activities. , 1997, Molecular biology of the cell.

[45]  K. Horwitz,et al.  New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP. , 1994, Cancer research.

[46]  W. Wilmanns,et al.  Effect of onapristone and medroxyprogesterone acetate on the proliferation and hormone receptor concentration of human breast cancer cells , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[47]  Lawrence A Leiter,et al.  Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin. , 1992, The Journal of clinical investigation.

[48]  R. Sutherland,et al.  Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes , 1991, Molecular and cellular biology.

[49]  T. Maudelonde,et al.  Regulation of fatty acid synthetase by progesterone in normal and tumoral human mammary glands. , 1990, Revista espanola de fisiologia.

[50]  D. Chalbos,et al.  Fatty acid synthetase and its mRNA are induced by progestins in breast cancer cells. , 1987, The Journal of biological chemistry.

[51]  D. Chalbos,et al.  A 250-kilodalton cellular protein is induced by progestins in two human breast cancer cell lines MCF7 and T47D. , 1984, Biochemical and biophysical research communications.

[52]  R. Chatterton,et al.  Progesterone-specific stimulation of triglyceride biosynthesis in a breast cancer cell line (T-47D). , 1983, Cancer research.

[53]  K. Shimura,et al.  Antitumor effect of palmitoleic acid on Ehrlich ascites tumor. , 1982, Cancer letters.

[54]  D. Chalbos,et al.  Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D). , 1982, The Journal of clinical endocrinology and metabolism.

[55]  R. Kalkhoff.  Metabolic effects of progesterone. , 1982, American journal of obstetrics and gynecology.

[56]  J. Baird,et al.  Effect of progesterone on lipid metabolism in the intact rat. , 1981, The Journal of endocrinology.

[57]  J. Kwiatkowski,et al.  Lipogenetic and glycolytic enzyme activities in carcinoma and nonmalignant diseases of the human breast. , 1979, British Journal of Cancer.

[58]  V. Turkington,et al.  Effects of Medroxyprogesterone Acetate on Carbohydrate Metabolism , 1974, Obstetrics and gynecology.

[59]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[60]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[61]  K. Horwitz,et al.  Unliganded progesterone receptors attenuate taxane-induced breast cancer cell death by modulating the spindle assembly checkpoint , 2011, Breast Cancer Research and Treatment.

[62]  D. Spandidos,et al.  Reversal of tumor resistance to apoptotic stimuli by alteration of membrane fluidity: therapeutic implications. , 2007, Advances in cancer research.

[63]  K. Lyseng-Williamson,et al.  Docetaxel: a review of its use in metastatic breast cancer. , 2005, Drugs.

[64]  S. Urien,et al.  Docetaxel serum protein binding with high affinity to alpha1-acid glycoprotein , 2004, Investigational New Drugs.

[65]  G. Owen,et al.  Glucose transporters: expression, regulation and cancer. , 2002, Biological research.

[66]  M. Hesselink,et al.  Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids , 2001, Histochemistry and Cell Biology.

[67]  K. Horwitz,et al.  Progestin action and progesterone receptor structure in human breast cancer: a review. , 1985, Recent progress in hormone research.

[68]  D. Epps,et al.  Rapid separation of lipid classes in high yield and purity using bonded phase columns. , 1985, Journal of lipid research.

[69]  E. Smith,et al.  Physical, metabolic, and hormonal effects on men of long-term therapy with medroxyprogesterone acetate. , 1985, Fertility and sterility.